BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Janssen Pharmaceutica N.V. 

Turnhoutseweg 30

Beerse  Antwerpen  2340  Belgium
Phone: 32-14602226 Fax:


SEARCH JOBS




Industry
Pharmaceutical


Collaborations

Vertex Pharmaceuticals (MA)  (telaprevir for HCV) - Europe, South America, Australia, the Middle East and other countries





 Company News
Galapagos NV (GLPG.BR) Initiates Phase 1 Study With GLPG1690, Triggering €6.6 M Milestone In The Alliance With Janssen Pharmaceutica N.V. 7/1/2014 9:13:37 AM
Janssen Pharmaceutica N.V. To Present New Simeprevir Data At The International Liver Congress™ 2014 Of The European Association For The Study Of The Liver (EASL) 3/24/2014 9:49:06 AM
Janssen Pharmaceutica N.V. Release: New Data Show XEPLION® Significantly Delays Time To Relapse Compared To Treatment As Usual With Oral Antipsychotic Monotherapy 3/4/2014 9:59:54 AM
Jubilant BioSys Ltd. Announces Expansion Of Drug Discovery Alliance With Janssen Pharmaceutica N.V. 2/19/2014 7:14:37 AM
Janssen Pharmaceutica N.V. Unveils New Data On Xeplion® In Various Stages Of Schizophrenia 12/1/2013 10:02:42 PM
Galapagos NV (GLPG.BR) Initiates Phase 1 Trial as Part of Its Alliance With Janssen Pharmaceutica N.V. 7/2/2013 10:43:47 AM
Janssen Pharmaceutica N.V., Funds New Global Mental Health Scholarships as Part of Its Healthy Minds Program 3/5/2013 1:09:43 PM
Galapagos NV (GLPG.BR) Delivers Candidate Drug in Its Alliance With Janssen Pharmaceutica N.V. and Receives $5.3 Million Milestone Payment 1/16/2013 8:53:53 AM
New Janssen Pharmaceutica N.V. Data Demonstrate STELARA® (ustekinumab) is Effective, Well-Tolerated and Improved Quality of Life in Patients With Moderate to Severe Plaque Psoriasis 9/28/2012 10:07:12 AM
ImmuNext Enters Into a Strategic Partnership With Janssen Pharmaceutica N.V. to Develop Novel Immunotherapies for the Treatment of Cancer 9/5/2012 9:59:40 AM
123456